Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × giredestrant × Breast × Clear all

Phase

Phase 3 6 Phase 2 6 Phase 1 3 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 71 Paclitaxel 63 Cyclophosphamide 56 pembrolizumab 53 Fulvestrant 40 Carboplatin 40 Capecitabine 37 Docetaxel 32 Letrozole 25 Doxorubicin 23 palbociclib 21 pertuzumab 19 eribulin 17 Nivolumab 17 ribociclib 16 abemaciclib 16 Gemcitabine 16 130-nm albumin-bound paclitaxel 16 durvalumab 15 Everolimus 15 Albumin-Bound Paclitaxel 15 sacituzumab govitecan 14 Lapatinib 14 Filgrastim 14 fludarabine 13 Taxes 13 Bevacizumab 13 exemestane 12 Cisplatin 12 olaparib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07100106 2026-04-21

MoonROSE

Genentech, Inc.

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡